Article Versions Notes

Lasaviciute G, Höbinger A, Ujvari D, Salamon D, Yusuf A, Sundin M, Sverremark-Ekström E, Chikhi R, Nilsson A, Saghafian-Hedengren S. Human Bone Marrow Mesenchymal Stromal Cell-Derived CXCL12, IL-6 and GDF-15 and Their Capacity to Support IgG-Secreting Cells in Culture Are Divergently Affected by Doxorubicin. Hemato. 2021; 2(1):154-166. https://doi.org/10.3390/hemato2010009

Lasaviciute, Gintare, Anna Höbinger, Dorina Ujvari, Daniel Salamon, Aisha Yusuf, Mikael Sundin, Eva Sverremark-Ekström, Rayan Chikhi, Anna Nilsson, and Shanie Saghafian-Hedengren. 2021. "Human Bone Marrow Mesenchymal Stromal Cell-Derived CXCL12, IL-6 and GDF-15 and Their Capacity to Support IgG-Secreting Cells in Culture Are Divergently Affected by Doxorubicin" Hemato 2, no. 1: 154-166. https://doi.org/10.3390/hemato2010009

Lasaviciute, G., Höbinger, A., Ujvari, D., Salamon, D., Yusuf, A., Sundin, M., Sverremark-Ekström, E., Chikhi, R., Nilsson, A., & Saghafian-Hedengren, S. (2021). Human Bone Marrow Mesenchymal Stromal Cell-Derived CXCL12, IL-6 and GDF-15 and Their Capacity to Support IgG-Secreting Cells in Culture Are Divergently Affected by Doxorubicin. Hemato, 2(1), 154-166. https://doi.org/10.3390/hemato2010009